
Centene Corp (CNC) received a 72% rating from Validea's Peter Lynch P/E/Growth Investor model, marking its highest score among the guru strategies Validea tracks, yet this score falls below the 80% threshold typically indicating strategy interest. The large-cap healthcare stock demonstrated strengths in PEG ratio, earnings per share, and debt-to-equity, but failed the inventory-to-sales test and showed neutral free cash flow and net cash positions, suggesting a mixed fundamental outlook despite its relative strength within Validea's analysis.
Centene Corp (CNC) presents a mixed but moderately positive fundamental picture based on Validea's Peter Lynch P/E/Growth Investor model, where it achieved its highest score of 72% across 22 guru strategies. This score, however, falls short of the 80% threshold typically indicating model interest. The analysis highlights specific strengths, as CNC passed criteria for its Yield Adjusted P/E to Growth (PEG) ratio, Earnings Per Share performance, and Total Debt/Equity ratio, suggesting it possesses attractive GARP (Growth at a Reasonable Price) characteristics and a solid balance sheet. Conversely, the model flagged notable weaknesses, with CNC failing the 'Inventory to Sales' test, which can be a red flag for operational efficiency. Furthermore, its 'Free Cash Flow' and 'Net Cash Position' were rated as neutral, indicating these areas are neither particular strengths nor weaknesses, contributing to the nuanced overall assessment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment